EUVIMEDEUVIMED entdecken
Crossref

Role of Erythropoietin in anemia of prematurity

Mohammad Mohammed, Haider Mohammad

Journal of Sulaimani Medical College · 21.06.2026 · 16 (1)

DOI: 10.17656/jsmc.10509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Sulaimani Medical College, online erschienen am 21.06.2026. Verfasst von Mohammad Mohammed und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anemia of prematurity (AOP) is a common condition in preterm infants, typically manifesting within the first few weeks of life and reaching a hemoglobin nadir of 7–8 g/dL by 4–6 weeks. Erythropoietin, a glycoprotein hormone, has a key role in stimulating erythropoiesis. Aim of study: To investigate the role of late recombinant erythropoietin therapy in decreasing the need for red blood cell transfusions and preventing anemia of prematurity.

Methods

A randomized controlled trial was conducted in the hospital. During 6 6-month period, forty preterm neonates with gestational age 28–34 weeks and birth weight 900–2000 g were randomly assigned to two groups. The treatment group received rHuEPO (400 IU/kg, subcutaneously, three times per week) from the second week of life, combined with iron (6 mg/kg/day) and QuatreFolate (400 μg/day). The control group received only iron and QuatreFolate. Therapy continued for four weeks while all infants were on enteral feeding.

Result

Delayed initiation of rHuEPO combined with iron supplementation significantly reduced the requirement for blood transfusions compared with controls (20% vs 55%, p = 0.04). The treatment group also showed higher reticulocyte counts (p = 0.01) and higher final hematocrit levels (p = 0.015). No adverse effects were observed.

Conclusion

Late administration of rHuEPO in combination with iron enhances erythropoiesis and reduces the need for transfusion in preterm infants. However, the inclusion of relatively stable, lower-risk neonates may limit the generalizability of the findings

Zitieren

APA

Mohammed, M., & Mohammad, H. (2026). Role of Erythropoietin in anemia of prematurity. Journal of Sulaimani Medical College, 16(1). https://doi.org/10.17656/jsmc.10509

Vancouver

Mohammed M, Mohammad H. Role of Erythropoietin in anemia of prematurity. Journal of Sulaimani Medical College. 2026;16(1). doi:10.17656/jsmc.10509

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Mohammad and Mohammad, Haider},
  title = {Role of Erythropoietin in anemia of prematurity},
  journal = {Journal of Sulaimani Medical College},
  year = {2026},
  volume = {16},
  number = {1},
  doi = {10.17656/jsmc.10509}
}
Kostenlos starten →